Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 470Erstellt: 23. Oktober 2026

4-amino-N-(1-methoxypropan-2-yl)benzene-1-sulfonamide → 4-[[4-[(2,6-Dimethyl-3-pyridinyl)oxy]-2-pyridinyl]amino]-N-(2-methoxy-1-methylethyl)benzenesulfonamide

https://huagongshe.com/de/reaction/470

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt4-amino-N-(1-methoxypropan-2-yl)benzene-1-sulfonamideHCID 5019568—
Edukt3-(2-Chloropyridin-4-yl)oxy-2,6-dimethyl-pyridineHCID 44598200—
ReagenzCesium carbonateHCID 10796—
Katalysator1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
KatalysatorPalladium (II) acetateHCID 4144353—
LösungsmittelDimethylacetamideHCID 31374—
Produkt4-[[4-[(2,6-Dimethyl-3-pyridinyl)oxy]-2-pyridinyl]amino]-N-(2-methoxy-1-methylethyl)benzenesulfonamideHCID 6894213051,97%

Reaktionsbedingungen

Temperatur150 °C

Reaktionsschritte

In a 10 mL microwave reactor 3-(2-chloropyridin-4-yloxy)-2,6-dimethylpyridine (100 mg, 0.43 mmol) and 4-amino-N-(1-methoxypropan-2-yl)benzenesulfonamide (104 mg, 0.43 mmol) were dissolved in DMA (3 mL) to give a brown solution.To the resultant solution Cesium carbonate (0.068 mL, 0.85 mmol) was added and sparged with nitrogen for 1 minute. Then Palladium(II) acetate (6.70 mg, 0.03 mmol) and 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (29.6 mg, 0.05 mmol) were added and the reaction mixture was sealed. The reaction was heated to150 °C for 25 minutes in the biotage microwave.The reaction was cooled to room temperature and LCMS shows reaction was completed. Reaction mixture was filtered through Celite Bed and washed with Dichloromethane. Filtrate was subjected to concentration to get DMA solution which was given to analytical department to purify using Mass based HPLC. After purification compound was isolated to get pale yellow solid of 4-(4-(2,6-dimethylpyridin-3-yloxy)pyridin-2-ylamino)-N-(1-methoxypropan-2-yl)benzenesulfonamide (98 mg, 52.0 %)

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-067637c197bb4672875d64a38b7940ee
Quellennotiz750 AstraZeneca ELN dataset